2mg Retatrutide: Reconstitution and Units to Draw

2mg retatrutide: how many units to draw

There is no single answer to "2mg retatrutide is how many units" until two numbers are fixed: the total milligrams in the vial, and the volume of bacteriostatic (BAC) water you reconstitute it with. Those two numbers set the concentration, and the concentration sets the draw.

The unit marks on a standard U-100 insulin syringe count hundredths of a millilitre: 100 units = 1mL, so 1 unit = 0.01mL. To convert any milligram dose to units you first work out how many millilitres of solution contain that dose, then multiply by 100. The retatrutide calculator guide walks through the same logic interactively.

2mg appears in the published phase 2 obesity trial as a low initial escalation dose: participants assigned to the higher target doses began at 2mg or 4mg and titrated upward every few weeks, and starting at 2mg was associated with fewer gastrointestinal side effects than starting at 4mg (Jastreboff et al., NEJM 2023). This page is a measurement reference, not a recommendation to use that dose.

The reconstitution math, step by step

Three steps take you from a dry vial to a unit count:

1. Concentration = total mg in vial ÷ mL of BAC water added. Example: a 10mg vial in 2mL of water is 10 ÷ 2 = 5mg/mL.
2. Volume for the dose = dose in mg ÷ concentration in mg/mL. Example: 2mg ÷ 5mg/mL = 0.4mL.
3. Units = volume in mL × 100. Example: 0.4mL × 100 = 40 units.

The same chain works for any peptide. If the milligram-to-millilitre relationship is unfamiliar, how mg/mL works and syringe units explained cover the underlying conversions.

2mg dose chart by vial size and BAC water fill

Retatrutide is commonly supplied as 10mg, 15mg or 20mg of lyophilised powder per vial. The table below gives the units to draw for a 2mg dose at three common BAC water fills, on a U-100 syringe. Figures are rounded to one decimal place.

Notice that 2mg lands on the same 20-unit mark from a 10mg vial in 1mL and a 20mg vial in 2mL: both are 10mg/mL. The concentration is what matters, not the vial label alone.

Choosing a fill that keeps the draw readable

A fill that puts a 2mg dose at an awkward fraction of a unit is harder to measure accurately. Whole or half-unit landing points are easier to hit on a U-100 syringe.

For a 10mg vial, 2mL of BAC water places 2mg at a clean 40 units, with each future titration step (4mg, 8mg) also landing on tidy marks. For a 15mg vial, the 2mg dose at 1mL (13.3 units) or 2mL (26.7 units) falls between marks, whereas 3mL gives a clean 40 units. The how much BAC water should I add guide explains the trade-off between concentration and total injection volume.

Reading the result on your syringe

Confirm three things before trusting the number: the syringe is U-100 (not U-40 or U-50, which use different scales), the marks are single units rather than 2-unit increments, and the total volume for the dose fits inside the barrel. A 60-unit draw needs a syringe with at least 100-unit capacity to be comfortable.

If your syringe prints in 2-unit steps, an odd-unit result such as 13.3 cannot be measured precisely, which is another reason to pick a fill that lands on a clean mark. For a refresher on the scale, see how to read an insulin syringe.

Why a 2mg start, and what the evidence actually shows

Retatrutide is an investigational triple agonist at the GIP, GLP-1 and glucagon receptors. It is not FDA-approved and remains in clinical trials; using it outside a supervised trial or licensed prescription is not established as safe, and dosing decisions belong with a clinician (Kaur & Misra, Eur J Clin Pharmacol 2024).

The 2mg figure comes from the dose-escalation design of the phase 2 obesity trial, where participants assigned to higher target doses started at 2mg or 4mg; a 2mg initial dose was linked to fewer gastrointestinal adverse events than a 4mg start (Jastreboff et al., NEJM 2023). A separate phase 2 trial studied retatrutide in metabolic dysfunction-associated steatotic liver disease (Sanyal et al., Nature Medicine 2024). Both are early-phase results, not licensing-grade safety data.

What users report (anecdotal, not medical advice): community write-ups commonly describe starting low to limit nausea before titrating upward. These are unverified personal accounts and carry no clinical weight; this page exists only to make the unit arithmetic correct.

FAQs